
Image by Pixabay on Pexels.com
Scientists Find A Gut Microbe That Could Help Aging Muscles Stay Strong
In A Nutshell
- Scientists identified a gut bacterium, Roseburia inulinivorans, that is linked to greater muscle strength in both younger and older adults.
- In a controlled mouse study, giving the bacterium orally boosted grip strength by roughly 30 percent without any exercise.
- The bacterium appears to trigger metabolic changes inside muscle tissue that promote fiber growth and increased power output.
- Levels of R. inulinivorans tend to decline with age, making it a potential probiotic target for age-related muscle loss.
Mice that never exercised became about 30 percent stronger. The rodents didn’t change their diets at all either. Researchers traced the effect to a single species of gut bacteria, a microbe called Roseburia inulinivorans that may play a meaningful role in how muscles grow and function.
In a study published in the journal Gut, researchers gave the bacterium to mice whose gut microbiomes had been wiped clean with antibiotics. Within four weeks, grip strength rose sharply and stayed elevated through the end of the eight-week experiment. Changes deep inside muscle tissue, including larger individual fibers and a shift toward more powerful fiber types, likely drove the gains.
For most people, building muscle means hitting the gym. But these findings raise a different question: what if the gut has been quietly shaping strength all along, and what if restoring a single missing bacterium could help people who can no longer exercise their way out of muscle loss?
Gut Bacteria and Muscle Strength: What the Human Data Showed
Before the mouse experiments, researchers at Leiden University Medical Center and the University of Granada examined the gut microbiomes of 123 adults: 90 young adults between 18 and 25, and 33 older adults around age 68. Participants submitted stool samples and had their muscle strength measured through handgrip tests and leg and bench press exercises.
Among all the bacteria analyzed, R. inulinivorans was the one most strongly linked to muscle strength. Older adults who had detectable levels of the bacterium showed handgrip strength about 29 percent higher than those with none. In the younger cohort, those with the highest levels tended to perform better across the strength tests measured. Two closely related species from the same bacterial family, R. faecis and R. intestinalis, showed no such association, pointing to something particular about R. inulinivorans rather than a general trait of the group.
No Treadmill Needed: How Gut Bacteria Built Stronger Muscles in Mice
To find out whether R. inulinivorans was actually causing the strength differences, researchers conducted a controlled mouse study. Thirty-two male mice had their gut bacteria cleared with antibiotics, then were split into four groups. One received a control solution; the other three each received oral doses of one of the three Roseburia species, three times per week for eight weeks.
Only mice given R. inulinivorans got stronger. Grip strength rose roughly 30 percent above controls by week four and held at that level through the end of the study. Mice receiving the other two species showed no improvement. None of the groups did better on treadmill endurance tests, suggesting the effect was more specific to muscle strength than to overall fitness. Food intake and body fat were unchanged across the board.
The Mechanism: What Was Happening Inside the Muscle
Roseburia bacteria are well known for producing butyrate, a compound that feeds gut cells and has been widely studied for its health benefits. Researchers initially looked there for an explanation. Butyrate levels came back essentially identical across all groups, so that was ruled out.
What they found instead was a notable drop in amino acids, protein’s basic building blocks, in the guts and bloodstreams of mice given R. inulinivorans. At the same time, muscle tissue showed clear signs of ramped-up metabolic activity, with several muscle pathways linked to energy use and growth becoming more active. Researchers suggest this shift may help muscles adapt and grow under changing nutrient conditions, though the precise chain of events is still being worked out.
The physical results were measurable. Muscle fibers in R. inulinivorans-treated mice grew larger, and fast-twitch fibers, the type associated with power and explosive strength, made up a significantly higher proportion of total muscle tissue than in control animals. Researchers also found a parallel metabolic pattern in young human participants with the highest levels of R. inulinivorans, suggesting the biology seen in mice may carry over to people.
Why Gut Bacteria and Muscle Strength Both Decline With Age
Older adults had lower levels of R. inulinivorans than younger ones across the researchers’ own participants, a trend also suggested in larger datasets, though results there were mixed. Other Roseburia species showed no such age-related pattern.
Prior research has found R. inulinivorans undetectable in some people already diagnosed with sarcopenia, the medical term for age-related muscle wasting. More broadly, the Roseburia genus has turned up at lower levels in people with conditions tied to muscle loss, including cerebral palsy, anorexia nervosa, and cachexia, the severe muscle and weight loss that often accompanies advanced cancer.
One additional finding, cited by the authors from a separate study, points to a possible two-way relationship. Six weeks of resistance training in sedentary young adults increased Roseburia abundance by roughly 2 percent. Exercise may help sustain the bacterium, and the bacterium may help build the muscle.
In the mouse study, R. inulinivorans did not take up permanent residence in the gut, yet the strength gains held. Scientists suspect that even brief exposure may trigger lasting metabolic changes in muscle tissue. Human clinical trials have not yet been conducted, but for researchers trying to understand why muscles weaken with age and how to slow that process, a gut microbe that boosted strength in mice without exercise is a lead worth pursuing.
Disclaimer: This study was conducted primarily in mice and includes observational human data. Results should not be interpreted as evidence that probiotic supplements will improve muscle strength in people. Human clinical trials have not yet been conducted.
Paper Notes
Limitations
The human data showing links between R. inulinivorans and muscle strength are observational, meaning they cannot confirm cause and effect on their own. Long-term studies in humans are needed to determine whether shifts in this bacterium’s abundance actually drive changes in muscle function. None of the human-derived Roseburia strains achieved lasting colonization in the mouse gut, so the observed effects likely stem from transient metabolic signals rather than stable bacterial settlement. Broad-spectrum antibiotic use to clear the animals’ native gut bacteria before the experiment may also have influenced outcomes in ways that are difficult to isolate. Specific areas such as inflammation and neuromuscular signaling were not directly assessed.
Funding and Disclosures
Lead author Borja Martinez-Tellez was supported by a grant from the Spanish Ministry of Science (RYC2022-036473-I), co-funded by the European Social Fund Plus. Additional funding came from the Spanish Ministry of Economy and Competitiveness through the Fondo de Investigación Sanitaria del Instituto de Salud Carlos III, the European Regional Development Fund, and several other Spanish and Dutch research programs. A co-author received an EMBO postdoctoral fellowship. Martinez-Tellez, along with co-authors Milena Schönke, Lourdes Ortiz-Alvarez, Jonatan Ruiz, and Patrick Rensen, are inventors on an international patent titled “Improvement of Muscle Mass and Strength” (WO2024025418A1), derived from this research. No other competing interests were declared.
Publication Details
Title: Roseburia inulinivorans increases muscle strength Authors: Borja Martinez-Tellez, Milena Schönke, Artemiy Kovynev, Esther Garcia-Dominguez, Lourdes Ortiz-Alvarez, Aswin Verhoeven, Ranko Gacesa, Arnau Vich Vila, Quinten Raymond Ducarmon, David Jimenez-Pavon, Maria del Carmen Gomez-Cabrera, Rinse K Weersma, Wiep-Klaas Smits, Martin Giera, Jonatan R Ruiz, Patrick CN Rensen Journal: Gut (BMJ Group) DOI: 10.1136/gutjnl-2025-336980 Published: Epub ahead of print, March 10, 2026 Trial Registration: NCT02365129







